Hamid Mohseni1, Amit Kiran1, Reza Khorshidi1, Kazem Rahimi1,2. 1. The George Institute for Global Health, University of Oxford, Oxford Martin School, 34 Broad Street Oxford OX1 3BD, UK. 2. Oxford University Hospitals NHS Foundation Trust, Cardiology, Oxford, UK.
Abstract
Aims: Evidence supporting yearly influenza vaccination in patients with chronic heart failure (HF) is limited, consequently leading to inconsistent guideline recommendations. We aimed to investigate the impact of influenza vaccination on the risk of hospitalization in HF patients. Methods and results: We used linked primary and secondary health records in England between 1990 and 2013. Using a self-controlled case series design with conditional Poisson regression, we estimated the incidence rate ratio (IRR, 95% CI) of the number of hospitalizations in a year following vaccination with an adjacent vaccination-free year in the same individuals. We found the uptake of vaccination to be varied and generally low (49% in 2013). Among 59,202 HF patients, influenza vaccination was associated with a lower risk of hospitalization due to cardiovascular disease (0.73 [0.71, 0.76]), with more modest effects for hospitalization due to respiratory infections (0.83 [0.77, 0.90]), and all-cause hospitalizations (0.96 [0.95, 0.98]). The relative effects were somewhat greater in younger patients but with no material difference between men and women. In validation analyses, effects were not significant for consecutive years without vaccination (0.96 [0.92, 1.00]) or hospitalization due to cancer (1.02 [0.84, 1.22]). Conclusion: In HF patients, influenza vaccination is associated with reduced risk of hospitalizations, especially for cardiovascular disease. Improved efforts for wider uptake of vaccination among HF patients are needed. Published on behalf of the European Society of Cardiology. All rights reserved.
Aims: Evidence supporting yearly influenza vaccination in patients with chronic heart failure (HF) is limited, consequently leading to inconsistent guideline recommendations. We aimed to investigate the impact of influenza vaccination on the risk of hospitalization in HF patients. Methods and results: We used linked primary and secondary health records in England between 1990 and 2013. Using a self-controlled case series design with conditional Poisson regression, we estimated the incidence rate ratio (IRR, 95% CI) of the number of hospitalizations in a year following vaccination with an adjacent vaccination-free year in the same individuals. We found the uptake of vaccination to be varied and generally low (49% in 2013). Among 59,202 HF patients, influenza vaccination was associated with a lower risk of hospitalization due to cardiovascular disease (0.73 [0.71, 0.76]), with more modest effects for hospitalization due to respiratory infections (0.83 [0.77, 0.90]), and all-cause hospitalizations (0.96 [0.95, 0.98]). The relative effects were somewhat greater in younger patients but with no material difference between men and women. In validation analyses, effects were not significant for consecutive years without vaccination (0.96 [0.92, 1.00]) or hospitalization due to cancer (1.02 [0.84, 1.22]). Conclusion: In HF patients, influenza vaccination is associated with reduced risk of hospitalizations, especially for cardiovascular disease. Improved efforts for wider uptake of vaccination among HF patients are needed. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Lisa A Jackson; Michael L Jackson; Jennifer C Nelson; Kathleen M Neuzil; Noel S Weiss Journal: Int J Epidemiol Date: 2005-12-20 Impact factor: 7.196
Authors: Jacob A Udell; Rami Zawi; Deepak L Bhatt; Maryam Keshtkar-Jahromi; Fiona Gaughran; Arintaya Phrommintikul; Andrzej Ciszewski; Hossein Vakili; Elaine B Hoffman; Michael E Farkouh; Christopher P Cannon Journal: JAMA Date: 2013-10-23 Impact factor: 56.272
Authors: Connor A Emdin; Simon G Anderson; Thomas Callender; Nathalie Conrad; Gholamreza Salimi-Khorshidi; Hamid Mohseni; Mark Woodward; Kazem Rahimi Journal: BMJ Date: 2015-09-29
Authors: Mei Shang; Jessie R Chung; Michael L Jackson; Lisa A Jackson; Arnold S Monto; Emily T Martin; Edward A Belongia; Huong Q McLean; Manjusha Gaglani; Kempapura Murthy; Richard K Zimmerman; Mary Patricia Nowalk; Alicia M Fry; Brendan Flannery Journal: Vaccine Date: 2018-11-09 Impact factor: 3.641
Authors: Siva H Yedlapati; Safi U Khan; Swapna Talluri; Ahmed N Lone; Muhammad Zia Khan; Muhammad Shahzeb Khan; Ann M Navar; Martha Gulati; Heather Johnson; Seth Baum; Erin D Michos Journal: J Am Heart Assoc Date: 2021-03-13 Impact factor: 5.501
Authors: Sanjay Poudel; Fadi Shehadeh; Ioannis M Zacharioudakis; Giannoula S Tansarli; Fainareti N Zervou; Markos Kalligeros; Robertus van Aalst; Ayman Chit; Eleftherios Mylonakis Journal: Open Forum Infect Dis Date: 2019-04-02 Impact factor: 3.835
Authors: Nathalie Conrad; Andrew Judge; Dexter Canoy; Jenny Tran; Ana-Catarina Pinho-Gomes; Elizabeth R C Millett; Gholamreza Salimi-Khorshidi; John G Cleland; John J V McMurray; Kazem Rahimi Journal: JAMA Cardiol Date: 2019-11-01 Impact factor: 14.676